Attenuation of interleukin-1beta by pulsed electromagnetic fields after traumatic brain injury

Neuroscience Letters

Volumn 519, Issue 1, 2012, Pages 4-8

  Rasouli, Jonathan ^a   Lekhraj, Rukmani ^a   White, Nicholas M ^a   Flamm, Eugene S ^a   Pilla, Arthur A ^b   Strauch, Berish ^a   Casper, Diana ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

Author keywords

IL 1 ; Inflammation; Interleukin 1beta; PEMF; Pulsed electromagnetic fields; TBI; Traumatic brain injury

Indexed keywords

INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN; CEREBROSPINAL FLUID; CONTROLLED STUDY; CONTUSION; CYTOKINE RELEASE; ELECTROMAGNETIC FIELD; INJURY SEVERITY; MALE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SOFT TISSUE INJURY; TRAUMATIC BRAIN INJURY;

ANIMALS; BIOLOGICAL MARKERS; BRAIN INJURIES; ELECTRIC STIMULATION; ELECTRIC STIMULATION THERAPY; ENCEPHALITIS; INTERLEUKIN-1BETA; MALE; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 84861798086     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.089     Document Type: Note

References (35)

1. Black R.A., Kronheim S.R., Cantrell M., Deeley M.C., March C.J., Prickett K.S., Wignall J., Conlon P.J., Cosman D., Hopp T.P., Mochizuki D.Y. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. Journal of Biological Chemistry 1988, 263:9437-9442.
2. Brydon L., Edwards S., Jia H., Mohamed-Ali V., Zachary I., Martin J.F., Steptoe A. Psychological stress activates interleukin-1beta gene expression in human mononuclear cells. Brain, Behavior, and Immunity 2005, 19:540-546.
3. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nature Reviews Neuroscience 2007, 8:766-775.
4. Cederberg D., Siesjo P. What has inflammation to do with traumatic brain injury?. Childs Nervous System 2010, 26:221-226.
5. Clausen F., Hanell A., Bjork M., Hillered L., Mir A.K., Gram H., Marklund N. Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. European Journal of Neuroscience 2009, 30:385-396.
6. Edwards P., Arango M., Balica L., Cottingham R., El-Sayed H., Farrell B., Fernandes J., Gogichaisvili T., Golden N., Hartzenberg B., Husain M., Ulloa M.I., Jerbi Z., Khamis H., Komolafe E., Laloe V., Lomas G., Ludwig S., Mazairac G., Munoz Sanchez Mde L., Nasi L., Olldashi F., Plunkett P., Roberts I., Sandercock P., Shakur H., Soler C., Stocker R., Svoboda P., Trenkler S., Venkataramana N.K., Wasserberg J., Yates D., Yutthakasemsunt S. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005, 365:1957-1959.
7. Faul M., Xu L., Wald M., Coronado V. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006 2010, Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Atlanta, GA.
8. Gavett B.E., Stern R.A., McKee A.C. Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clinics in Sports Medicine 2011, 30:179-188. xi.
9. Gossling H.R., Bernstein R.A., Abbott J. Treatment of ununited tibial fractures: a comparison of surgery and pulsed electromagnetic fields (PEMF). Orthopedics 1992, 15:711-719.
10. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., Moskowitz M.A. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:2007-2012.
11. A. Helmy, M.G. De Simoni, M.R. Guilfoyle, K.L. Carpenter, P.J. Hutchinson, Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury, Progress in Neurobiology 95 (2011) 352-372.
12. Holmin S., Mathiesen T. Intracerebral administration of interleukin-1beta and induction of inflammation, apoptosis, and vasogenic edema. Journal of Neurosurgery 2000, 92:108-120.
13. Homsi S., Federico F., Croci N., Palmier B., Plotkine M., Marchand-Leroux C., Jafarian-Tehrani M. Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Research 2009, 1291:122-132.
14. Itoh M., Montemayor J.S., Matsumoto E., Eason A., Lee M.H., Folk F.S. Accelerated wound healing of pressure ulcers by pulsed high peak power electromagnetic energy (Diapulse). Decubitus 1991, 4:24-25. 29-34.
15. Kamm K., Vanderkolk W., Lawrence C., Jonker M., Davis A.T. The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. Journal of Trauma 2006, 60:152-157.
16. Kim Y.M., Talanian R.V., Li J., Billiar T.R. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). Journal of Immunology 1998, 161:4122-4128.
17. Maas A.I., Marmarou A., Murray G.D., Teasdale S.G., Steyerberg E.W. Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. Journal of Neurotrauma 2007, 24:232-238.
18. Marmarou A., Foda M.A., van den Brink W., Campbell J., Kita H., Demetriadou K. A new model of diffuse brain injury in rats. Part I. Pathophysiology and biomechanics. Journal of Neurosurgery 1994, 80:291-300.
19. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. Journal of Neuroscience 2008, 28:9451-9462.
20. Medawar P.B. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. British Journal of Experimental Pathology 1948, 29:58-69.
21. Nirogi R., Kandikere V., Mudigonda K., Bhyrapuneni G., Muddana N., Saralaya R., Benade V. A simple and rapid method to collect the cerebrospinal fluid of rats and its application for the assessment of drug penetration into the central nervous system. Journal of Neuroscience Methods 2009, 178:116-119.
22. Pennington G.M., Danley D.L., Sumko M.H., Bucknell A., Nelson J.H. Pulsed, non-thermal, high-frequency electromagnetic energy (DIAPULSE) in the treatment of grade I and grade II ankle sprains. Military Medicine 1993, 158:101-104.
23. Pilla A.A., Fitzsimmons R.J., Muehsam D.J., Rohde C., Wu J.K., Casper D. Electromagnetic fields as first messenger in biological signaling: application to calmodulin-dependent signaling in tissue repair. Biochimica et Biophysica Acta 2011, 1810:1236-1245.
24. Pinteaux E., Trotter P., Simi A. Cell-specific and concentration-dependent actions of interleukin-1 in acute brain inflammation. Cytokine 2009, 45:1-7.
25. Rohde C., Chiang A., Adipoju O., Casper D., Pilla A.A. Effects of pulsed electromagnetic fields on interleukin-1 beta and postoperative pain: a double-blind, placebo-controlled, pilot study in breast reduction patients. Plastic and Reconstructive Surgery 2010, 125:1620-1629.
26. Sanderson K.L., Raghupathi R., Saatman K.E., Martin D., Miller G., McIntosh T.K. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury. Journal of Cerebral Blood Flow and Metabolism 1999, 19:1118-1125.
27. Shiozaki T., Hayakata T., Tasaki O., Hosotubo H., Fuijita K., Mouri T., Tajima G., Kajino K., Nakae H., Tanaka H., Shimazu T., Sugimoto H. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 2005, 23:406-410.
28. Sosin D.M., Sacks J.J., Smith S.M. Head injury-associated deaths in the United States from 1979 to 1986. Journal of the American Medical Association 1989, 262:2251-2255.
29. Tehranian R., Andell-Jonsson S., Beni S.M., Yatsiv I., Shohami E., Bartfai T., Lundkvist J., Iverfeldt K. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. Journal of Neurotrauma 2002, 19:939-951.
30. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J., Elliston K.O., Ayala J.M., Casano F.J., Chin J., Ding G.J.-F., Egger L.A., Gaffney E.P., Glimjuco G., Palyha O.C., Raju S.M., Rolando A.M., Salley J.P., Yamin T.-T., Lee T.D., Shively J.E., MacCross M., Mumford R.A., Schmidt J.A., Tocci M.J. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992, 356:768-774.
31. Toulmond S., Rothwell N.J. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Research 1995, 671:261-266.
32. Varani K., Gessi S., Merighi S., Iannotta V., Cattabriga E., Spisani S., Cadossi R., Borea P.A. Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. British Journal of Pharmacology 2002, 136:57-66.
33. Varani K., Vincenzi F., Targa M., Corciulo C., Fini M., Setti S., Cadossi R., Borea P.A. Effect of pulsed electromagnetic field exposure on adenosine receptors in rat brain. Bioelectromagnetics 2012, 33:279-287.
34. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995, 26:676-680. discussion 681.
35. Ziebell J.M., Morganti-Kossmann M.C. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010, 7:22-30.